NASDAQ:MTAC MedTech Acquisition (MTAC) Stock Forecast, Price & News $10.45 +0.04 (+0.38%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$10.43▼$10.4550-Day Range$10.19▼$10.4552-Week Range$9.80▼$10.68Volume8,277 shsAverage Volume1,337 shsMarket Capitalization$85.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About MedTech Acquisition (NASDAQ:MTAC) StockMedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.Read More Receive MTAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address MTAC Stock News HeadlinesMay 30, 2023 | msn.comMorgan Stanley's top medtech picks are Medtronic, Alphatec, Becton DickinsonMay 10, 2023 | investing.comLAVA Medtech Acquisition Corp (LVAC)June 3, 2023 | Legacy Research (Affiliate) (Ad)The “Amazon Secret Royalty Program” Can Help Anyone Retire Like RoyaltyA unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.April 26, 2023 | forbes.comSix Ways To Lead The Charge In MedtechApril 20, 2023 | finance.yahoo.comTriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver MetastasesApril 19, 2023 | americanbankingnews.comMedTech Acquisition (NASDAQ:MTAC) and Elekta AB (publ) (OTCMKTS:EKTAY) Head to Head SurveyApril 7, 2023 | americanbankingnews.comComparing Akumin (NASDAQ:AKU) & MedTech Acquisition (NASDAQ:MTAC)February 21, 2023 | finance.yahoo.comTriSalus Life Sciences Appoints James Alecxih to Lead Device Technology BusinessJune 3, 2023 | Legacy Research (Affiliate) (Ad)The “Amazon Secret Royalty Program” Can Help Anyone Retire Like RoyaltyA unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.December 8, 2022 | yahoo.comMedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of StockholdersNovember 16, 2022 | finance.yahoo.comTriSalus Goes SPAC Way To Fund Pressure-Enabled Drug Delivery Tech Based Cancer TrialsNovember 14, 2022 | finance.yahoo.comTriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition CorporationAugust 9, 2022 | finance.yahoo.comGlobal MedTech Healthcare IT Industry Competitive LandscapeJuly 27, 2022 | apnews.comLSI Emerging Medtech Summit 2022 Brings Venture Capital and Entrepreneurs Closer in New Event in EuropeJuly 15, 2022 | benzinga.comOphthalmic Devices Market is expected to be worth USD 83.1 billion by 2030, with a CAGR of 4.7%.June 12, 2022 | seekingalpha.comMedtronic: Stable Growth AheadMay 31, 2022 | msn.com3 Med-Tech Stocks With Incredible PotentialMay 27, 2022 | seekingalpha.comMedtronic plc (MDT) CEO Geoff Martha on Q4 2022 Results - Earnings Call TranscriptApril 8, 2022 | finance.yahoo.comMedTech Acquisition Corporation (MTAC)March 10, 2022 | seekingalpha.comSPAC MedTech Acquisition, Memic Innovative Surgery call off planned mergerDecember 30, 2021 | finance.yahoo.comA look at the South Florida tech companies that were acquired or went public in 2021November 13, 2021 | nasdaq.comMedTech Acquisition Corporation Class A Common Stock (MTAC)October 7, 2021 | nasdaq.comHow Much Of MedTech Acquisition Corporation (NASDAQ:MTAC) Do Institutions Own?September 9, 2021 | finance.yahoo.comMemic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition CorporationSeptember 4, 2021 | investing.comMedTech Acquisition Corp (MTAC)August 23, 2021 | bizjournals.comTechnology & Innovation Roundup: Memic Innovative Surgery to go public in SPAC mergerAugust 13, 2021 | markets.businessinsider.comMemic Going Public Via SPAC: What Investors Should Know About This Medical Device CompanySee More Headlines MTAC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MTAC Company Calendar Today6/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MTAC CUSIPN/A CIK1826667 WebN/A Phone908-391-1288FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$5.54 million Net MarginsN/A Pretax MarginN/A Return on Equity-17.92% Return on Assets1.66% Debt Debt-to-Equity RatioN/A Current Ratio0.06 Quick Ratio0.06 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.89 per share Price / Cash Flow11.75 Book Value($1.69) per share Price / Book-6.18Miscellaneous Outstanding Shares8,200,000Free Float1,952,000Market Cap$85.69 million OptionableNot Optionable Beta-0.03 Key ExecutivesMr. Christopher C. Dewey (Age 79)CEO & Director Mr. David J. Matlin J.D. (Age 61)CFO & Director Mr. Robert H. Weiss J.D. (Age 64)Chief Admin. Officer & Sec. Key CompetitorsPersonalisNASDAQ:PSNLGenetronNASDAQ:GTHDermTechNASDAQ:DMTKSera PrognosticsNASDAQ:SERABiodesixNASDAQ:BDSXView All CompetitorsInstitutional OwnershipSkyView Investment Advisors LLCBought 150,000 shares on 5/18/2023Ownership: 1.829%Graham Capital Wealth Management LLCBought 6,893 shares on 5/10/2023Ownership: 0.084%Virtu Financial LLCSold 1,973 shares on 5/1/2023Ownership: 0.126%View All Institutional Transactions MTAC Stock - Frequently Asked Questions How have MTAC shares performed in 2023? MedTech Acquisition's stock was trading at $10.03 at the beginning of 2023. Since then, MTAC shares have increased by 4.2% and is now trading at $10.45. View the best growth stocks for 2023 here. What is MedTech Acquisition's stock symbol? MedTech Acquisition trades on the NASDAQ under the ticker symbol "MTAC." Who are MedTech Acquisition's major shareholders? MedTech Acquisition's stock is owned by many different institutional and retail investors. Top institutional investors include SkyView Investment Advisors LLC (1.83%), Virtu Financial LLC (0.13%) and Graham Capital Wealth Management LLC (0.08%). How do I buy shares of MedTech Acquisition? Shares of MTAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is MedTech Acquisition's stock price today? One share of MTAC stock can currently be purchased for approximately $10.45. How much money does MedTech Acquisition make? MedTech Acquisition (NASDAQ:MTAC) has a market capitalization of $85.69 million. How can I contact MedTech Acquisition? MedTech Acquisition's mailing address is 1345 AVENUE OF THE AMERICAS, NEW YORK NY, 10105. The company can be reached via phone at 908-391-1288. This page (NASDAQ:MTAC) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedTech Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.